×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INO – inovio pharmaceuticals, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/24
05:57 pm
ino
INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Low
Report
INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
2/24
04:04 pm
ino
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
Low
Report
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
2/24
10:16 am
ino
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Low
Report
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
2/24
09:00 am
ino
Investors in Inovio Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO
Medium
Report
Investors in Inovio Pharmaceuticals, Inc. Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO
2/24
08:00 am
ino
Holzer & Holzer, LLC Reminds INO Investors of the April 7, 2026 Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Securities Class Action
Medium
Report
Holzer & Holzer, LLC Reminds INO Investors of the April 7, 2026 Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Securities Class Action
2/23
03:51 pm
ino
Levi & Korsinsky, LLP: Cellectra Device Manufacturing Practices at Center of Inovio Pharmaceuticals Securities Litigation
Low
Report
Levi & Korsinsky, LLP: Cellectra Device Manufacturing Practices at Center of Inovio Pharmaceuticals Securities Litigation
2/23
01:06 pm
ino
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Low
Report
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
2/23
12:00 pm
ino
Bronstein, Gewirtz & Grossman LLC Urges Inovio Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Inovio Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
MISS
Report
-7.0%
inovio pharmaceuticals, inc.
8/12/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
14.1%
inovio pharmaceuticals, inc.
5/13/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-2.1%
inovio pharmaceuticals, inc.
3/18/2025
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-8.4%
inovio pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/17
04:44 pm
ino
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Alyeska Investment Group, L.P.
Low
Report
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Alyeska Investment Group, L.P.
1/30
02:21 pm
ino
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: VANGUARD GROUP INC
1/27
04:17 pm
ino
Form 424B5 INOVIO PHARMACEUTICALS,
Low
Report
Form 424B5 INOVIO PHARMACEUTICALS,
1/27
04:13 pm
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Jan 27
Neutral
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Jan 27
12/29
08:20 am
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Dec 29
High
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Dec 29
12/8
11:45 am
ino
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: JANUS HENDERSON GROUP PLC
12/5
02:04 pm
ino
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: FMR LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/3
Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800
66.7%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
TOP News Decliners
3/9
Form 8-K INOVIO PHARMACEUTICALS, For: Mar 03
-47.6%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: